Latest news
Loading news…
REGENXBIO
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Rockville, Maryland, United States Founded 2009 251-500 employees For Profit
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
342
Ticker
RGNX
NASDAQ
Patents
101
43 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- RGNX
- Exchange
- NASDAQ
- IPO date
- Sep 8, 2015
- Raised at IPO
- $138M
- Valuation at IPO
- $492M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 19
- Active products
- 19
- Patents granted
- 101
- Trademarks
- 43
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $3.69M
Company Info
- Founded
- 2009
- Employees
- 251-500
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 443
- HQ
- Rockville, Maryland, United States
- Region
- Washington DC Metro Area, East Coast, Southern US
- Exit date
- Sep 8, 2015
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 3.2
- Trend (90d)
- 0.2
- Last leadership hire
- Mar 13, 2025
- Last layoff mention
- Nov 9, 2023
Key People at REGENXBIO
Chief Scientific Officer
Executive Vice President & Chief Medical Officer
Vice President, Market Access
Chief Executive Officer and President
GLP Quality Assurance Manager
CFO
Chief Executive Officer, President and Director
342
professional contacts at REGENXBIO
Contact execs at REGENXBIO →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to REGENXBIO
Loading news…
FAQs about REGENXBIO
People who checked this page also checked these
Browse the full Acquirezy directory.